NCT06097169View on ClinicalTrials.gov

Evaluation of the Postoperative Agitation Prevention and Analgesic Efficacy of Perioperative Dexmedetomidine Infusion in a Pediatric Patient Group to Undergo Dental Treatment

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

October 10, 2023

Primary Completion Date

February 20, 2024

Study Completion Date

February 25, 2024

Conditions
AnxietyPostoperative PainNausea
Interventions
DRUG

Fentanyl

In Group dex, dexmedetomidine infusion will be administered to the patient during the operation. Fentanyl bolus dose will be administered during anesthesia induction in group Fen.

DRUG

Dexmedetomidine

In Group dex, dexmedetomidine infusion will be administered to the patient during the operation. Fentanyl bolus dose will be administered during anesthesia induction in group Fen.

Trial Locations (1)

34400

Istanbul Medipol University, Istanbul

All Listed Sponsors
lead

Medipol University

OTHER

NCT06097169 - Evaluation of the Postoperative Agitation Prevention and Analgesic Efficacy of Perioperative Dexmedetomidine Infusion in a Pediatric Patient Group to Undergo Dental Treatment | Biotech Hunter | Biotech Hunter